V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006136 | 280003795 | 1.47 | null | Neo-adjuvant (N) | null | 2016-06-26 | Y-90 | N | null | 280030339 | EURO-EWING |
| 280006137 | 280003795 | null | 95.9 | Adjuvant (A) | 2017-02-17 | 2017-02-18 | GEMCARBO | N | null | 280030339 | CISPLATIN + DOXORUBICIN |
| 280006138 | 280003795 | null | 77 | Curative (C) | 2014-12-07 | 2014-12-08 | ECX | N | N | 280030339 | DE-ESCALATE TRIAL |
| 280006139 | 280003796 | 1.7 | 63.3 | Curative (C) | 2017-08-14 | 2017-09-13 | Doxorubicin + Olaratumab | N | N | 280030344 | CISPLATIN + VINORELBINE |
| 280006140 | 280008063 | 1.54 | 40.5 | Curative (C) | 2014-04-02 | 2014-04-19 | Carboplatin + Pemetrexed | 02 | Y | 280030346 | EURO-EWING |
| 280006141 | 280003797 | 1.73 | 77 | Palliative (P) | 2017-05-13 | 2017-05-17 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 280030348 | OXALIPLATIN + MDG |
| 280006142 | 280003798 | 1.62 | 51.2 | Palliative (P) | 2017-07-13 | 2017-07-13 | GEMCARBO | N | N | 280030350 | FCIST |
| 280006143 | 280008064 | 1.61 | null | Adjuvant (A) | 2014-08-03 | 2014-08-12 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 02 | N | 280030351 | GEMCARBO |
| 280006144 | 280003799 | 1.79 | 84.7 | Palliative (P) | 2015-08-17 | 2015-08-21 | Bendamustine+Rituximab (1st Course) | 02 | N | 280030353 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 280006145 | 280003800 | 1.61 | null | Curative (C) | 2018-06-29 | 2018-07-02 | CISPLATIN + ETOPOSIDE | N | N | 280030354 | CISPLATIN + FLUOROURACIL + RT |
| 280006146 | 280008065 | 1.64 | 48.3 | Palliative (P) | 2018-04-15 | 2018-05-05 | Paclitaxel 80mg/m2 day 1 8 15 | Y | N | 280030355 | DOXORUBICIN + OLARATUMAB |
| 280006147 | 280008065 | 1.89 | null | Curative (C) | 2016-07-13 | 2016-07-19 | PEMBROLIZUMAB | N | N | 280030355 | VIDE |
| 280006148 | 280003801 | null | null | Curative (C) | null | 2016-12-05 | Liposomal Doxorubicin (20mg/m2) | Y | null | 280030360 | IVADO |
| 280006149 | 280003802 | 1.65 | 109.9 | Neo-adjuvant (N) | 2016-09-28 | 2016-09-28 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280030362 | CARBO + FLUOROURACIL |
| 280006150 | 280008066 | 1.7 | 72.9 | Curative (C) | 2017-10-09 | 2017-10-20 | VIDE | 99 | null | 280030371 | CISPLATIN + FLUOROURACIL + RT |
| 280006151 | 280008066 | 1.74 | 85.6 | Palliative (P) | 2013-04-30 | 2013-05-08 | Capecitabine + Oxaliplatin 21day | 2 | N | 280030371 | LIPOSOMAL DOXORUBICIN |
| 280006152 | 280003803 | 1.56 | 58.6 | null | null | 2018-02-09 | Gemcitabine weekly | null | null | 280030373 | EC |
| 280006153 | 280003803 | 1.63 | null | null | 2016-03-23 | 2016-03-24 | Gemcitabine weekly | N | N | 280030373 | MELPHALAN |
| 280006154 | 280003804 | 1.65 | 95.6 | Adjuvant (A) | 2015-08-28 | 2015-08-28 | LIPOSOMAL DOXORUBICIN | N | N | 280030378 | CARBO + FLUOROURACIL |
| 280006155 | 280003804 | null | 83 | Palliative (P) | null | 2016-07-05 | GemCarbo Days 1+8 | N | N | 280030378 | DOXORUBICIN + OLARATUMAB |
| 280006156 | 280003805 | null | 116.8 | Curative (C) | 2014-05-11 | 2014-06-09 | VAC | N | Y | 280030383 | EURO-EWING |
| 280006157 | 280003805 | null | null | Curative (C) | 2013-09-11 | 2013-10-22 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280030383 | DE-ESCALATE TRIAL |
| 280006158 | 280010095 | 1.98 | 62.4 | null | 2012-10-11 | 2014-01-17 | PACLITAXEL | N | N | 280030386 | VIDE |
| 280006159 | 280003806 | 1.8 | 73 | Palliative (P) | null | 2017-10-28 | VIDE | N | N | 280030387 | DOXORUBICIN + OLARATUMAB |
| 280006160 | 280003806 | 1.77 | null | Curative (C) | 2013-11-27 | 2013-12-04 | LIPOSOMAL DOXORUBICIN | N | N | 280030387 | CISPLATIN + FLUOROURACIL + RT |
| 280006161 | 280003807 | 1.64 | 8.4 | null | 2016-02-09 | 2016-02-24 | MELPHALAN | N | null | 280030393 | GEMCITABINE |
| 280006162 | 280003807 | 1.57 | 73 | Palliative (P) | 2017-11-22 | 2017-12-04 | LIPOSOMAL DOXORUBICIN | 02 | N | 280030393 | EPIRUBICIN |
| 280006163 | 280003808 | 1.54 | null | Curative (C) | null | 2016-03-22 | Docetaxel + Gemcitabine with GCSF | null | null | 280030395 | COMPARE TRIAL |
| 280006164 | 280003809 | 1.75 | 71 | Curative (C) | 2017-07-28 | 2017-07-28 | Carbo F | 02 | N | 280030398 | DOXORUBICIN + HD MTX |
| 280006165 | 280003809 | 1.84 | 80.9 | Palliative (P) | 2013-09-02 | 2013-09-21 | Abiraterone | N | N | 280030398 | CCEP |
| 280006166 | 280003810 | 1.64 | 80.2 | Palliative (P) | 2017-09-17 | 2017-09-29 | ECX | 2 | N | 280030400 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 280006167 | 280003810 | 0 | 65.4 | Adjuvant (A) | 2016-12-22 | 2016-12-27 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 280030400 | CARBO + FLUOROURACIL |
| 280006168 | 280003810 | null | 75.8 | Curative (C) | 2017-05-29 | 2017-05-29 | IVA | null | null | 280030400 | VIDE |
| 280006169 | 280003811 | 1.5 | 66.3 | Palliative (P) | 2019-02-15 | 2019-02-23 | OCTREOTIDE | N | N | 280030403 | DOCETAXEL + GEMCITABINE |
| 280006170 | 280003811 | null | null | null | 2013-02-18 | 2013-02-18 | Mitomycin Intravesical | Y | N | 280030403 | IVADO |
| 280006171 | 280003812 | 1.59 | null | Palliative (P) | 2014-08-11 | 2014-08-15 | Cisplatin + Fluorouracil + RT 5day | N | null | 280030407 | PACLITAXEL |
| 280006172 | 280003812 | 1.75 | 66.3 | Palliative (P) | 2017-06-11 | 2017-06-11 | IPILIMUMAB + NIVOLUMAB | 2 | N | 280030407 | IDELALISIB |
| 280006173 | 280010097 | 1.61 | 59.4 | Palliative (P) | 2016-08-21 | 2016-09-10 | IMATINIB | N | N | 280030410 | GEMCITABINE |
| 280006174 | 280011110 | 1.65 | 88.3 | Curative (C) | 2013-04-12 | 2013-04-17 | VIDE | 02 | N | 280030411 | IRINOTECAN + TEMOZOLOMIDE |
| 280006175 | 280003813 | 1.76 | 66.6 | Palliative (P) | null | 2016-09-17 | DE-ESCALATE TRIAL | null | null | 280030412 | CYCLOPHOSPHAMIDE |
| 280006176 | 280003813 | 1.7 | 99 | Curative (C) | 2017-05-20 | 2017-05-23 | CARBOPLATIN + VINORELBINE | N | N | 280030412 | EURO-EWING |
| 280006177 | 280003814 | 1.67 | 96.8 | Curative (C) | 2017-10-29 | 2017-10-29 | Paclitaxel 7 day | 02 | N | 280030416 | EURO-EWING |
| 280006178 | 280003815 | 1.79 | 63.3 | Neo-adjuvant (N) | 2015-06-15 | 2015-06-16 | Carboplatin + Pemetrexed | N | N | 280030417 | VIDE |
| 280006179 | 280003815 | 1.69 | 70.1 | Palliative (P) | 2014-05-16 | 2014-05-29 | Liposomal Doxorubicin 50mg/m2 | 02 | Y | 280030417 | CHOP R |
| 280006180 | 280003816 | 0 | 86.3 | Palliative (P) | 2014-10-01 | 2014-10-08 | Liposomal Doxorubicin 50mg/m2 | N | N | 280030419 | CVP R |
| 280006181 | 280008078 | 1.86 | 87 | Palliative (P) | 2016-10-14 | 2016-11-04 | GEMCITABINE | N | null | 280030420 | CARBO + FLUOROURACIL |
| 280006182 | 280003817 | 1.69 | null | Adjuvant (A) | 2015-05-09 | 2015-05-13 | IVA | 02 | N | 280030421 | TRABECTEDIN |
| 280006183 | 280008079 | 1.83 | 78.4 | Palliative (P) | 2013-08-02 | 2013-08-02 | Bevacizumab 5mg/kg | 02 | N | 280030424 | CETUXIMAB + CISPLATIN + FU |
| 280006184 | 280008079 | 1.61 | 102 | Palliative (P) | 2015-07-23 | 2015-08-11 | CAPECITABINE + OXALIPLATIN | Y | N | 280030424 | PEMBROLIZUMAB |
| 280006187 | 280003819 | 1.55 | 43 | Not known (9) | null | 2013-07-08 | GemCarbo Days 1+8 | 2 | N | 280030432 | PACLITAXEL |